Skip to main content
IMPL logo

Impel Pharmaceuticals Inc. (IMPL) Stock Analysis

DELISTED

What happened to Impel Pharmaceuticals Inc. (IMPL) stock?

Impel Pharmaceuticals Inc. (IMPL) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Vol: 720.0K| 52-wk range: $0.0212 – $4.20
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Impel Pharmaceuticals Inc. (IMPL). Impel Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on therapies for central nervous system diseases.

Last analyzed: Mar 17, 2026
Impel Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on therapies for central nervous system diseases. Their lead product, Trudhesa, targets acute migraine, while they also develop treatments for agitation in autism and OFF episodes in Parkinson's disease.

Impel Pharmaceuticals Inc. (IMPL) Healthcare & Pipeline Overview

Employees160
Model self-rating on this text: 71% (not a measure of the evidence) Updated: Mar 17, 2026

More about this archive record

Can I still buy IMPL shares?

No. IMPL stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IMPL elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before IMPL stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Impel Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.